Bajetta E, Chiara Stani S, De Candis D, et al. Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial. Cancer. 2000;89:763-768.

Beretta GD, Michetti G, Belometti MO, et al. Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer. Br J Cancer. 2000;83:573-576.

Greco FA, Gray JR Jr, Thompson DS, et al. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a Minnie Pearl Cancer Research Network trial. Cancer. 2002;95:1279-1285.

Gridelli C, Frontini L, Perrone F, et al, for the Gem Vin Investigators. Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Br J Cancer. 2000;83:707-714.

Gridelli C, Shepherd F, Perrone F, et al. Gemvin III: a phase III study of gemcitabine plus vinorelbine (GV) compared to cisplatin plus vinorelbine or gemcitabine chemotherapy (PCT) for stage IIIb or IV non-small cell lung cancer (NSCLC): an Italo-Canadian study [abstract]. Proc Am Soc Clin Oncol. 2002;21:292a. Abstract 1165.

Herbst RS, Khuri FR, Lu C, et al. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. Cancer. 2002;95:340-353.

Lilenbaum R, Cano R, Schwartz M, et al. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study. Cancer. 2000;88:557-562.

Lilenbaum RC, Herndon J, List M, et al. Single-agent (SA) versus combination chemotherapy (CC) in advanced non-small cell lung cancer (NSCLC): a CALGB randomized trial of efficacy, quality of life (QOL), and cost-effectiveness [abstract]. Proc Am Soc Clin Oncol. 2002;21:1a. Abstract 2.

Lorusso V, Carpagnano F, Frasci G, et al. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol. 2000;18:405-411.

Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92-98.

Van Meerbeeck JP, Smit EF, Lianes P, et al. A EORTC randomized phase III Trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC) [abstract]. Proc Am Soc Clin Oncol. 2001;20:308a. Abstract 1228.